LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COMMON STOCK
Shares outstanding
363,214,619
Total 13F shares
106,140,794
Share change
-297,701
Total reported value
$1,917,259,558
Put/Call ratio
54%
Price per share
$18.07
Number of holders
138
Value change
+$249,235
Number of buys
79
Number of sells
60

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q3 2016

As of 30 Sep 2016, LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 106,140,794 shares. The largest 10 holders included Artal Group S.A., FMR LLC, UBS ASSET MANAGEMENT AMERICAS INC, VANGUARD GROUP INC, BlackRock Fund Advisors, NEA Management Company, LLC, EAGLE ASSET MANAGEMENT INC, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., and COLUMBUS CIRCLE INVESTORS. This page lists 138 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.